Page 15 - Lymphoma Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.

Validation of Novel Prognostic Index May Better Inform Burkitt Lymphoma Treatment Research by Rutgers Cancer Institute of New Jersey and RWJBarnabas Health researcher and international collaborators can help identify prognosis and stratify risk News provided by Share this article (PRNewsfoto/Rutgers Cancer Institute of New Jersey and RWJBarnabas Health) NEW BRUNSWICK, N.J., Jan. 28, 2021 /PRNewswire/ -- Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and a National Cancer Institute- designated Comprehensive Cancer Center, together with RWJBarnabas Health, tod...